P

Inventor

HARTMAN GEORGE D

US172 patents
⚠️ This page may combine multiple inventors who share the name “HARTMAN GEORGE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

35 patents
US6306874B1Oct 23, 2001

Tyrosine kinase inhibitors

MERCK & CO INC214 citations99
US5856326AJan 5, 1999

Inhibitors of farnesyl-protein transferase

MERCK & CO INC280 citations99
US6875767B2Apr 5, 2005

(5-cyano-2-thiazolyl)amino-4-pyridine tyrosine kinase inhibitors

MERCK & CO INC87 citations98
US6794393B1Sep 21, 2004

Tyrosine kinase inhibitors

MERCK & CO INC75 citations98
US6586423B2Jul 1, 2003

Tyrosine kinase inhibitors

MERCK & CO INC151 citations98
US6420382B2Jul 16, 2002

Tyrosine kinase inhibitors

MERCK & CO INC120 citations98
US6313138B1Nov 6, 2001

Tyrosine kinase inhibitors

MERCK & CO INC130 citations98
US6066738AMay 23, 2000

Inhibitors of farnesyl-protein transferase

MERCK & CO INC94 citations98
US6927293B2Aug 9, 2005

Tyrosine kinase inhibitors

MERCK & CO INC69 citations97
US6586424B2Jul 1, 2003

Tyrosine kinase inhibitors

MERCK & CO INC95 citations97
US6048861AApr 11, 2000

Integrin receptor antagonists

MERCK & CO INC100 citations97
US5854245ADec 29, 1998

Fibrinogen receptor antagonists

MERCK & CO INC103 citations97
US6040311AMar 21, 2000

Integrin receptor antagonists

MERCK & CO INC64 citations96
US5968965AOct 19, 1999

Inhibitors of farnesyl-protein transferase

MERCK & CO INC85 citations96
US5814643ASep 29, 1998

Sulfonamide fibrinogen receptor antagonists

MERCK & CO INC48 citations96
US5741796AApr 21, 1998

Pyridyl and naphthyridyl compounds for inhibiting osteoclast-mediated bone resorption

MERCK & CO INC82 citations96
US5719144AFeb 17, 1998

Fibrinogen receptor antagonists

MERCK & CO INC77 citations96
US5292756AMar 8, 1994

Novel sulfonamide fibrinogen receptor antagonists

MERCK & CO INC56 citations96
US5227490AJul 13, 1993

Fibrinogen receptor antagonists

MERCK & CO INC73 citations96
US5116870AMay 26, 1992

HMG-CoA reductase inhibitors

MERCK & CO INC62 citations96
US4940727AJul 10, 1990

Novel HMG-CoA reductase inhibitors

MERCK & CO INC52 citations96
US4751231AJun 14, 1988

Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents

MERCK & CO INC56 citations96
US6958340B2Oct 25, 2005

Tyrosine kinase inhibitors

MERCK & CO INC73 citations95
US5281585AJan 25, 1994

Fibrinogen receptor antagonists for inhibiting aggregation of blood platelets

MERCK & CO INC107 citations95
US4735956AApr 5, 1988

Certain 1,4-dihydro-2,6-di-lower hydrocarbyl-4-heterocyclic-3,5-pyridine dicarboxylates which are useful as calcium channel blockers

MERCK & CO INC53 citations95
US5559127ASep 24, 1996

Fibrinogen receptor antagonists

MERCK & CO INC41 citations94
US5272158ADec 21, 1993

Fibrinogen receptor antagonists

MERCK & CO INC68 citations94
US6297249B1Oct 2, 2001

Integrin receptor antagonists

MERCK & CO INC18 citations93
US6090948AJul 18, 2000

Inhibitors of farnesyl-protein transferase

MERCK & CO INC47 citations93
US5952341ASep 14, 1999

Integrin antagonists

MERCK & CO INC49 citations93
US5925655AJul 20, 1999

αv β3 antagonists

MERCK & CO INC28 citations93
US5130306AJul 14, 1992

5-Oxygenated HMG-COA reductase inhibitors

MERCK & CO INC49 citations93
US5098931AMar 24, 1992

7-substituted HMG-CoA reductase inhibitors

MERCK & CO INC49 citations93
US4963538AOct 16, 1990

5-oxygenated HMG-CoA reductase inhibitors

MERCK & CO INC46 citations93
US4897402AJan 30, 1990

5-oxa, 5-thia, 5-aza HmG-CoA reductase inhibitors

MERCK & CO INC54 citations93

NOVIRA THERAPEUTICS INC

14 patents
US9181288B2Nov 10, 2015

Azepane derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC103 citations98
US9066932B2Jun 30, 2015

Hepatitis B antiviral agents

NOVIRA THERAPEUTICS INC39 citations97
US9061008B2Jun 23, 2015

Hepatitis B antiviral agents

NOVIRA THERAPEUTICS INC39 citations97
US9505722B2Nov 29, 2016

Azepane derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC24 citations94
US9400280B2Jul 26, 2016

Piperidine derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC24 citations94
US9339510B2May 17, 2016

Azepane derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC25 citations94
US9169212B2Oct 27, 2015

Azepane derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC28 citations94
US8993771B2Mar 31, 2015

Hepatitis B antiviral agents

NOVIRA THERAPEUTICS INC36 citations94
US9579313B2Feb 28, 2017

Hepatitis B antiviral agents

NOVIRA THERAPEUTICS INC19 citations93
US9205079B2Dec 8, 2015

Hepatitis B antiviral agents

NOVIRA THERAPEUTICS INC25 citations93
US9676747B2Jun 13, 2017

Hepatitis B antiviral agents

NOVIRA THERAPEUTICS INC20 citations92
US9550779B2Jan 24, 2017

Derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC10 citations92
US9527845B2Dec 27, 2016

Derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC11 citations92
US9518057B2Dec 13, 2016

Derivatives and methods of treating hepatitis B infections

NOVIRA THERAPEUTICS INC10 citations92

HARTMAN GEORGE D

1 patent

Showing the top 50 of 172 patents by PatentIndex Score.